Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

631 articles

Research Review

Showing 1–1 of 1 articles · Keyword: AAV gene therapy Clear keyword

Frontiers in molecular neuroscience2026ReviewNon-viral Gene Delivery

1. Restoring Parkin function: an AAV gene therapy approach for early-onset Parkinson's disease

Basu S, Demarest Tg, Gattone Nj, Gilsrud Aj, Wicks B, Khatiwada A, Et Al.

Biallelic loss-of-function mutations in PRKN gene (encoding Parkin protein) cause early-onset Parkinson's disease (EOPD). Parkin is a crucial component of the PINK1-Parkin pathway, which marks damaged mitochondria for degradation via mitophagy. Without functional Parkin, damaged mitochondria accumulate, causing…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.